Major Depressive Disorder

Latest News

Seltorexant for Major Depressive Disorder With Insomnia Symptoms Sees Positive Results

May 30th 2024

Research on MDD treatments seltorexant and Spravato (esketamine) CIII nasal spray shared at 2024 ASCP Annual Meeting.

How can we enhance our lithium research?
Securing the Future of Lithium Research

May 27th 2024

Here are highlights from the week in Psychiatric Times.
The Week in Review: May 20-24

May 25th 2024

A more useful measure than BMI or waist circumference? Researchers analyzed the association between weight-adjusted waist index and depressive symptoms.
Weight-Adjusted Waist Index and Depressive Symptoms in a Nationally Representative Sample

May 23rd 2024

weight gain
New Data on Psychiatric Polypharmacy and Unwanted Weight Gain

May 22nd 2024

Latest CME Events & Activities

Clinical Consultations™: Considerations for Customizing Care Plans for Patients with Parkinson Disease Psychosis

View More

Advances In™ Schizophrenia: Expanding the Therapeutic Landscape

View More

Expert Illustrations & Commentaries™: Visualizing New Therapeutic Targets in Schizophrenia

View More

Southern California Psychiatry Conference

September 13-14, 2024

Register Now!

Updates on New and Emerging Therapies to Improve Outcomes for Patients With Major Depressive Disorder

View More

5th Annual International Congress on the Future of Neurology®

View More

2023 Annual Psychiatric Times™ World CME Conference

View More

Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II

View More

Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments

View More

Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies

View More

'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care

View More

Real Psychiatry 2025

January 2025 - Exact Date TBA

View More

More Than ‘Blue’ After Birth: Managing Diagnosis and Treatment of Post-Partum Depression

View More

Patient, Provider & Caregiver Connection™: Reducing the Burden of Parkinson Disease Psychosis with Personalized Management Plans

View More

Expert Perspectives in the Recognition and Management of Postpartum Depression

View More

More News

© 2024 MJH Life Sciences

All rights reserved.